Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel traditional Chinese medicine for treating hypoleucocytosis caused by radiotherapy and chemotherapy for treating cancers and preparation method thereof

A technology of leukopenia, radiotherapy and chemotherapy, applied in the field of medicine, can solve the problems of secondary infectious diseases, decreased immune function, leukopenia, etc., and achieve the effect of definite clinical curative effect, improvement of bone marrow suppression, and stable content

Inactive Publication Date: 2012-07-11
SHAANXI UNIV OF CHINESE MEDICINE
View PDF1 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, after chemotherapy and radiotherapy, tumor patients experience leukopenia and decreased immune function, often secondary to other infectious diseases; TCM clinical manifestations include pale complexion, palpitation, shortness of breath, fatigue, insomnia, dry throat, and poor appetite. Tumor radiotherapy and chemotherapy are greatly restricted or forced to stop

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel traditional Chinese medicine for treating hypoleucocytosis caused by radiotherapy and chemotherapy for treating cancers and preparation method thereof
  • Novel traditional Chinese medicine for treating hypoleucocytosis caused by radiotherapy and chemotherapy for treating cancers and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033] Embodiment 1: Taking the production of oral liquid product 1000mL of the present invention as an example, its preparation method is:

[0034] 1) Extraction: take 100g of ginseng and 300g of astragalus, crush the original medicinal materials, heat and extract twice with 8 times of water, each time for 2 hours, filter, and combine the filtrates;

[0035] 2) Concentration: Concentrate the filtrate under reduced pressure to obtain a concentrated solution, the ratio of the concentrated solution is 1:0.25, that is, each milliliter of the concentrated solution contains 0.25 grams of the original medicinal material;

[0036] 3) Alcohol precipitation: Slowly add ethanol to the concentrated solution until the alcohol content is 30%, and let stand for 24 hours;

[0037] 4) Recovering ethanol: take the alcohol precipitation supernatant, filter, and recover ethanol under reduced pressure until there is no alcohol smell, and the concentration ratio of the medicinal solution is 1:1, t...

Embodiment 2

[0043] Embodiment 2: Taking the production of oral liquid product 1000mL of the present invention as an example, its preparation method is:

[0044] 1) Extraction: take 100g of ginseng and 300g of astragalus, crush the original medicinal materials, heat and extract with 5 times of water for 3 times, each time for 1 hour, filter, and combine the filtrates;

[0045] 2) Concentration: Concentrate the filtrate under reduced pressure to obtain a concentrated solution, the ratio of the concentrated solution is 1:0.5, that is, each milliliter of the concentrated solution contains 0.5 grams of the original medicinal material;

[0046] 3) Alcohol precipitation: Slowly add ethanol to the concentrated solution until the alcohol content reaches 40%, and let stand for 24 hours;

[0047] 4) Recovery of ethanol: take the alcohol precipitation supernatant, filter, and recover the ethanol under reduced pressure until there is no alcohol smell, and the concentration ratio of the medicinal solut...

Embodiment 3

[0053] Embodiment 3: Taking the production of oral liquid product 1000mL of the present invention as an example, its preparation method is:

[0054] 1) Extraction: take 100g of ginseng and 300g of astragalus, crush the original medicinal materials, heat and extract once with 40 times of water, 3 hours each time, filter, and combine the filtrates;

[0055] 2) Concentration: Concentrate the filtrate under reduced pressure to obtain a concentrated solution, the ratio of the concentrated solution is 1:1.5, that is, each milliliter of the concentrated solution contains 1.5 grams of the original medicinal material;

[0056] 3) Alcohol precipitation: Slowly add ethanol to the concentrated solution until the alcohol content is 20%, and let stand for 24 hours;

[0057] 4) Recovery of ethanol: take the alcohol precipitation supernatant, filter, and recover the ethanol under reduced pressure until there is no alcohol smell, and the concentration ratio of the medicinal solution is 1:1.5, th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Maximum tolerated doseaaaaaaaaaa
Login to View More

Abstract

The invention discloses a novel traditional Chinese medicine for treating hypoleucocytosis caused by radiotherapy and chemotherapy for treating cancers and a preparation method thereof, and also discloses pharmacological effects and clinical application of the novel traditional Chinese medicine. The novel traditional Chinese medicine provided by the invention comprises pearl ginseng and astragalus mongholicus. The preparation method of the novel traditional Chinese medicine comprises the following steps of adding water into pearl ginseng and astragalus mongholicus, respectively carrying out decoction extraction, merging the extract, carrying out concentration, carrying out alcohol precipitation, standing, recovering ethanol of supernate, carrying out condensation, and mixing the concentrated solution and one or more pharmaceutically acceptable carriers / auxiliary materials to obtain an oral solution, wherein the oral solution is the novel traditional Chinese medicine. The oral solution named as a pearl ginseng-astragalus mongholicus oral solution has active components of total saponins and plant polysaccharides, wherein the total saponins comprise ginsenoside Ro, panax japonicus saponin IVa and astragaloside IV. The oral solution can be utilized for treating diseases of hypoleucocytosis, lusterless complexion, mental and physical fatigue, palpitaition, shortness of breath, insomnia, dry throat and inappetence after radiotherapy and chemotherapy for treating cancers.

Description

technical field [0001] The invention belongs to the technical field of medicine, and relates to a new traditional Chinese medicine for treating leukopenia caused by cancer radiotherapy and chemotherapy and a preparation method thereof. Background technique [0002] Cancer is one of the diseases that seriously threaten human health and life. In my country, tumors also have a very high incidence rate. The number of deaths due to malignant tumors accounts for 17.9% of the total death toll in the country, which is the second largest cause of death. Judging from the current clinical anti-tumor methods, it mainly includes: surgical treatment, chemotherapy, radiotherapy, immunotherapy, gene therapy, traditional Chinese medicine treatment and comprehensive treatment of various treatment methods. Among them, surgical treatment, chemotherapy and radiotherapy, as the main methods and means of clinical treatment, have played an important role in relieving the suffering of patients, prol...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/481A61P7/00A61P35/00
Inventor 宋小妹崔九成范少敏蒙跃龙张旋宋蓓王薇冯改利
Owner SHAANXI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com